ArticleFrontiers in cardiovascular medicine2022

Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study.

Yinghong Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.